| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | CD93 FBLN7 FAM20C FBN1 FBN2 HMCN1 MEGF6 ASAH2 DLL3 LRP2 LRP4 LTBP2 CD320 DLL1 ADAM8 F7 LDLR CRB2 | 1.39e-12 | 749 | 57 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.93e-08 | 188 | 57 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.20e-05 | 16 | 57 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.83e-05 | 21 | 57 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 7.96e-05 | 5 | 57 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.02e-04 | 85 | 57 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 2.07e-04 | 190 | 57 | 5 | GO:0004252 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.14e-04 | 430 | 57 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 3.08e-04 | 207 | 57 | 5 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 3.44e-04 | 212 | 57 | 5 | GO:0017171 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 5.19e-04 | 12 | 57 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 7.13e-04 | 14 | 57 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.19e-03 | 73 | 57 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | integrin binding | 1.57e-03 | 175 | 57 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | heparin binding | 2.20e-03 | 192 | 57 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | peptidase activity | 2.50e-03 | 654 | 57 | 7 | GO:0008233 | |
| GeneOntologyMolecularFunction | Notch binding | 2.68e-03 | 27 | 57 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.62e-03 | 891 | 57 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 4.48e-03 | 35 | 57 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 4.48e-03 | 35 | 57 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.89e-03 | 120 | 57 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | hormone activity | 6.78e-03 | 135 | 57 | 3 | GO:0005179 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 7.05e-03 | 599 | 57 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 7.18e-03 | 268 | 57 | 4 | GO:0005539 | |
| GeneOntologyBiologicalProcess | cobalamin transport | 2.37e-06 | 10 | 57 | 3 | GO:0015889 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.66e-05 | 412 | 57 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 3.83e-05 | 337 | 57 | 7 | GO:0006898 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 4.49e-05 | 4 | 57 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 7.46e-05 | 5 | 57 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | compartment pattern specification | 7.46e-05 | 5 | 57 | 2 | GO:0007386 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 7.76e-05 | 377 | 57 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | PTPN3 FAM20C FBN1 FBN2 CILP LRP2 LRP4 LTBP2 DLL1 F7 TNXB CRB2 | 7.85e-05 | 1186 | 57 | 12 | GO:0007167 |
| GeneOntologyBiologicalProcess | extracellular structure organization | 7.89e-05 | 378 | 57 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | endocytosis | 7.94e-05 | 827 | 57 | 10 | GO:0006897 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 8.02e-05 | 379 | 57 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 1.13e-04 | 34 | 57 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 1.27e-04 | 93 | 57 | 4 | GO:0099068 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.36e-04 | 883 | 57 | 10 | GO:0070848 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 1.56e-04 | 7 | 57 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 1.84e-04 | 40 | 57 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 2.08e-04 | 8 | 57 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 2.08e-04 | 8 | 57 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | odontogenesis of dentin-containing tooth | 2.19e-04 | 107 | 57 | 4 | GO:0042475 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 2.28e-04 | 43 | 57 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 2.45e-04 | 44 | 57 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 2.79e-04 | 46 | 57 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | cell fate determination | 3.58e-04 | 50 | 57 | 3 | GO:0001709 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 4.06e-04 | 11 | 57 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 4.06e-04 | 11 | 57 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis involved in cholesterol transport | 4.06e-04 | 11 | 57 | 2 | GO:0090118 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 4.86e-04 | 12 | 57 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 5.00e-04 | 850 | 57 | 9 | GO:0071363 | |
| GeneOntologyBiologicalProcess | vitamin transport | 5.00e-04 | 56 | 57 | 3 | GO:0051180 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 5.54e-04 | 58 | 57 | 3 | GO:0097106 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 5.74e-04 | 13 | 57 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 5.74e-04 | 13 | 57 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 6.15e-04 | 1269 | 57 | 11 | GO:0009887 | |
| GeneOntologyBiologicalProcess | import into cell | 6.49e-04 | 1074 | 57 | 10 | GO:0098657 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 6.68e-04 | 14 | 57 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial to mesenchymal transition | 7.06e-04 | 63 | 57 | 3 | GO:0010718 | |
| GeneOntologyBiologicalProcess | odontogenesis | 8.07e-04 | 151 | 57 | 4 | GO:0042476 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 8.78e-04 | 16 | 57 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 1.00e-03 | 71 | 57 | 3 | GO:0099084 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 1.03e-03 | 1141 | 57 | 10 | GO:0045597 | |
| GeneOntologyBiologicalProcess | protein processing | 1.13e-03 | 285 | 57 | 5 | GO:0016485 | |
| GeneOntologyBiologicalProcess | somitogenesis | 1.22e-03 | 76 | 57 | 3 | GO:0001756 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS10 NTN4 FBLN7 FBN1 FCGBP FBN2 HMCN1 MEGF6 CILP TNC LAMA2 LTBP2 F7 TNXB | 1.73e-09 | 656 | 57 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS10 NTN4 FBLN7 FBN1 FCGBP FBN2 HMCN1 MEGF6 CILP TNC LAMA2 LTBP2 F7 TNXB | 1.80e-09 | 658 | 57 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ADAMTS10 NTN4 FBN1 FBN2 HMCN1 MEGF6 CILP TNC LAMA2 LTBP2 F7 TNXB | 1.56e-08 | 530 | 57 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 5.39e-06 | 13 | 57 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.27e-05 | 17 | 57 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | basement membrane | 2.05e-05 | 122 | 57 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | tenascin complex | 4.37e-05 | 4 | 57 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | plasma membrane raft | 5.01e-05 | 147 | 57 | 5 | GO:0044853 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 6.73e-05 | 80 | 57 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | membrane raft | 4.46e-04 | 362 | 57 | 6 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 4.59e-04 | 364 | 57 | 6 | GO:0098857 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 5.61e-04 | 59 | 57 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | apical part of cell | 1.09e-03 | 592 | 57 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.06e-03 | 487 | 57 | 6 | GO:0016324 | |
| GeneOntologyCellularComponent | apicolateral plasma membrane | 2.64e-03 | 28 | 57 | 2 | GO:0016327 | |
| GeneOntologyCellularComponent | caveola | 3.46e-03 | 111 | 57 | 3 | GO:0005901 | |
| GeneOntologyCellularComponent | anchoring junction | 4.76e-03 | 976 | 57 | 8 | GO:0070161 | |
| HumanPheno | Microspherophakia | 4.16e-07 | 4 | 25 | 3 | HP:0030961 | |
| HumanPheno | Spherophakia | 1.04e-06 | 5 | 25 | 3 | HP:0034375 | |
| HumanPheno | Aplasia/Hypoplasia of the lens | 4.57e-05 | 15 | 25 | 3 | HP:0008063 | |
| HumanPheno | Lens dislocation | 4.90e-05 | 43 | 25 | 4 | HP:0000665 | |
| HumanPheno | Ectopia lentis | 4.90e-05 | 43 | 25 | 4 | HP:0001083 | |
| HumanPheno | Abnormal upper to lower segment ratio | 6.92e-05 | 3 | 25 | 2 | HP:0012772 | |
| HumanPheno | Broad skull | 6.92e-05 | 3 | 25 | 2 | HP:0002682 | |
| HumanPheno | High myopia | 7.63e-05 | 94 | 25 | 5 | HP:0011003 | |
| HumanPheno | Abnormality of lens shape | 8.12e-05 | 18 | 25 | 3 | HP:0011526 | |
| HumanPheno | Shallow anterior chamber | 8.12e-05 | 18 | 25 | 3 | HP:0000594 | |
| HumanPheno | Abnormal mitral valve morphology | 1.68e-04 | 257 | 25 | 7 | HP:0001633 | |
| HumanPheno | Iridodonesis | 2.29e-04 | 5 | 25 | 2 | HP:0100693 | |
| HumanPheno | Crumpled ear | 3.43e-04 | 6 | 25 | 2 | HP:0009901 | |
| MousePheno | abnormal bone mineral content | PTPN3 FAM20C FBN2 MEGF6 LRP2 TNRC6B SCAF11 ADAM32 DLL1 XKR4 F7 TNXB LCE2C TG | 1.20e-07 | 713 | 50 | 14 | MP:0010122 |
| MousePheno | decreased bone mineral content | FAM20C MEGF6 LRP2 TNRC6B SCAF11 ADAM32 DLL1 XKR4 F7 TNXB LCE2C | 5.67e-07 | 465 | 50 | 11 | MP:0010124 |
| MousePheno | abnormal bone structure | PTPN3 FAM20C FBN1 FBN2 MEGF6 DLL3 LRP2 LRP4 TNRC6B SCAF11 ADAM32 DLL1 XKR4 ADAM8 F7 TNXB LCE2C TG | 5.82e-07 | 1379 | 50 | 18 | MP:0003795 |
| MousePheno | abnormal cilary zonule morphology | 1.25e-05 | 2 | 50 | 2 | MP:0014176 | |
| Domain | EGF | CD93 HGFAC FBLN7 FBN1 FCGBP NRXN3 FBN2 HMCN1 MEGF6 NRXN2 TNC DLL3 BRINP2 LRP2 LAMA2 LRP4 LTBP2 MUC13 ADAM32 DLL1 ADAM8 F7 TNXB LDLR CRB2 | 1.04e-33 | 235 | 54 | 25 | SM00181 |
| Domain | EGF-like_dom | CD93 HGFAC FBLN7 FBN1 FCGBP NRXN3 FBN2 HMCN1 MEGF6 NRXN2 TNC DLL3 LRP2 LAMA2 LRP4 LTBP2 MUC13 ADAM32 DLL1 ADAM8 F7 TNXB LDLR CRB2 | 3.17e-31 | 249 | 54 | 24 | IPR000742 |
| Domain | EGF-like_CS | CD93 HGFAC NTN4 FBLN7 FBN1 NRXN3 FBN2 HMCN1 MEGF6 NRXN2 TNC DLL3 LRP2 LAMA2 LRP4 LTBP2 MUC13 ADAM32 DLL1 ADAM8 F7 TNXB LDLR CRB2 | 1.02e-30 | 261 | 54 | 24 | IPR013032 |
| Domain | EGF_1 | HGFAC NTN4 FBLN7 FBN1 NRXN3 FBN2 HMCN1 MEGF6 NRXN2 TNC DLL3 LRP2 LAMA2 LRP4 LTBP2 MUC13 ADAM32 DLL1 ADAM8 F7 TNXB LDLR CRB2 | 3.52e-29 | 255 | 54 | 23 | PS00022 |
| Domain | EGF_2 | CD93 HGFAC FBLN7 FBN1 NRXN3 FBN2 HMCN1 MEGF6 NRXN2 TNC DLL3 LRP2 LAMA2 LRP4 LTBP2 MUC13 ADAM32 DLL1 ADAM8 F7 TNXB LDLR CRB2 | 8.73e-29 | 265 | 54 | 23 | PS01186 |
| Domain | EGF_3 | CD93 HGFAC FBLN7 FBN1 NRXN3 FBN2 HMCN1 MEGF6 NRXN2 TNC DLL3 LRP2 LRP4 LTBP2 MUC13 ADAM32 DLL1 ADAM8 F7 TNXB LDLR CRB2 | 3.16e-28 | 235 | 54 | 22 | PS50026 |
| Domain | EGF | CD93 HGFAC FBLN7 NRXN3 HMCN1 MEGF6 NRXN2 TNC DLL3 LRP2 LRP4 LTBP2 DLL1 F7 TNXB CRB2 | 1.17e-22 | 126 | 54 | 16 | PF00008 |
| Domain | ASX_HYDROXYL | CD93 FBLN7 FBN1 NRXN3 FBN2 HMCN1 MEGF6 LRP2 LRP4 LTBP2 DLL1 F7 LDLR CRB2 | 1.68e-20 | 100 | 54 | 14 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | CD93 FBLN7 FBN1 NRXN3 FBN2 HMCN1 MEGF6 LRP2 LRP4 LTBP2 DLL1 F7 LDLR CRB2 | 3.98e-20 | 106 | 54 | 14 | IPR000152 |
| Domain | Growth_fac_rcpt_ | CD93 NTN4 FBN1 FBN2 HMCN1 MEGF6 TNC DLL3 LRP2 LRP4 LTBP2 MUC13 DLL1 TNXB LDLR | 2.21e-19 | 156 | 54 | 15 | IPR009030 |
| Domain | EGF_CA | CD93 FBLN7 FBN1 FBN2 HMCN1 MEGF6 DLL3 LRP2 LRP4 LTBP2 DLL1 F7 LDLR CRB2 | 3.11e-19 | 122 | 54 | 14 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | CD93 FBLN7 FBN1 FBN2 HMCN1 MEGF6 DLL3 LRP2 LRP4 LTBP2 DLL1 F7 LDLR CRB2 | 3.95e-19 | 124 | 54 | 14 | IPR001881 |
| Domain | EGF_Ca-bd_CS | CD93 FBLN7 FBN1 FBN2 HMCN1 MEGF6 LRP2 LRP4 LTBP2 DLL1 F7 LDLR CRB2 | 8.08e-19 | 97 | 54 | 13 | IPR018097 |
| Domain | EGF_CA | CD93 FBLN7 FBN1 FBN2 HMCN1 MEGF6 LRP2 LRP4 LTBP2 DLL1 F7 LDLR CRB2 | 1.07e-18 | 99 | 54 | 13 | PS01187 |
| Domain | EGF_CA | 5.07e-14 | 86 | 54 | 10 | PF07645 | |
| Domain | Ldl_recept_a | 5.64e-13 | 45 | 54 | 8 | PF00057 | |
| Domain | - | 6.81e-13 | 46 | 54 | 8 | 4.10.400.10 | |
| Domain | LDLRA_1 | 9.81e-13 | 48 | 54 | 8 | PS01209 | |
| Domain | LDLRA_2 | 1.17e-12 | 49 | 54 | 8 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.17e-12 | 49 | 54 | 8 | IPR002172 | |
| Domain | LDLa | 1.17e-12 | 49 | 54 | 8 | SM00192 | |
| Domain | EGF_extracell | 6.48e-12 | 60 | 54 | 8 | IPR013111 | |
| Domain | EGF_2 | 6.48e-12 | 60 | 54 | 8 | PF07974 | |
| Domain | LDLR_class-A_CS | 1.95e-11 | 40 | 54 | 7 | IPR023415 | |
| Domain | cEGF | 9.66e-11 | 26 | 54 | 6 | IPR026823 | |
| Domain | cEGF | 9.66e-11 | 26 | 54 | 6 | PF12662 | |
| Domain | hEGF | 1.56e-08 | 28 | 54 | 5 | PF12661 | |
| Domain | TB | 7.93e-07 | 7 | 54 | 3 | PF00683 | |
| Domain | - | 1.27e-06 | 8 | 54 | 3 | 3.90.290.10 | |
| Domain | TB | 1.90e-06 | 9 | 54 | 3 | PS51364 | |
| Domain | TB_dom | 1.90e-06 | 9 | 54 | 3 | IPR017878 | |
| Domain | LAM_G_DOMAIN | 4.28e-06 | 38 | 54 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 5.28e-06 | 40 | 54 | 4 | PF02210 | |
| Domain | LamG | 7.77e-06 | 44 | 54 | 4 | SM00282 | |
| Domain | Ldl_recept_b | 8.13e-06 | 14 | 54 | 3 | PF00058 | |
| Domain | LDLRB | 8.13e-06 | 14 | 54 | 3 | PS51120 | |
| Domain | LY | 1.01e-05 | 15 | 54 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.01e-05 | 15 | 54 | 3 | IPR000033 | |
| Domain | Laminin_G | 2.36e-05 | 58 | 54 | 4 | IPR001791 | |
| Domain | FBN | 2.46e-05 | 3 | 54 | 2 | IPR011398 | |
| Domain | DSL | 8.16e-05 | 5 | 54 | 2 | IPR001774 | |
| Domain | DSL | 8.16e-05 | 5 | 54 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 8.16e-05 | 5 | 54 | 2 | IPR011651 | |
| Domain | MNNL | 8.16e-05 | 5 | 54 | 2 | PF07657 | |
| Domain | TRYPSIN_SER | 1.33e-04 | 90 | 54 | 4 | IPR033116 | |
| Domain | Laminin_EGF | 1.40e-04 | 35 | 54 | 3 | PF00053 | |
| Domain | EGF_Lam | 1.40e-04 | 35 | 54 | 3 | SM00180 | |
| Domain | - | 1.63e-04 | 95 | 54 | 4 | 2.60.120.200 | |
| Domain | Syndecan | 1.71e-04 | 7 | 54 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.71e-04 | 7 | 54 | 2 | IPR027789 | |
| Domain | Laminin_EGF | 1.79e-04 | 38 | 54 | 3 | IPR002049 | |
| Domain | Peptidase_M12B_N | 1.94e-04 | 39 | 54 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.94e-04 | 39 | 54 | 3 | PF01562 | |
| Domain | - | 1.94e-04 | 39 | 54 | 3 | 2.120.10.30 | |
| Domain | DISINTEGRIN_1 | 2.09e-04 | 40 | 54 | 3 | PS00427 | |
| Domain | Reprolysin | 2.09e-04 | 40 | 54 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 2.09e-04 | 40 | 54 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.09e-04 | 40 | 54 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 2.09e-04 | 40 | 54 | 3 | IPR001590 | |
| Domain | TRYPSIN_HIS | 2.23e-04 | 103 | 54 | 4 | IPR018114 | |
| Domain | Disintegrin_dom | 2.25e-04 | 41 | 54 | 3 | IPR001762 | |
| Domain | TRYPSIN_SER | 2.49e-04 | 106 | 54 | 4 | PS00135 | |
| Domain | TRYPSIN_HIS | 2.58e-04 | 107 | 54 | 4 | PS00134 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.18e-04 | 46 | 54 | 3 | IPR011042 | |
| Domain | Peptidase_S1A | 3.18e-04 | 113 | 54 | 4 | IPR001314 | |
| Domain | TRYPSIN_DOM | 3.40e-04 | 115 | 54 | 4 | PS50240 | |
| Domain | Tryp_SPc | 3.63e-04 | 117 | 54 | 4 | SM00020 | |
| Domain | Trypsin | 4.13e-04 | 121 | 54 | 4 | PF00089 | |
| Domain | Trypsin_dom | 4.13e-04 | 121 | 54 | 4 | IPR001254 | |
| Domain | Peptidase_S1_PA | 4.39e-04 | 123 | 54 | 4 | IPR009003 | |
| Domain | TIL_dom | 7.30e-04 | 14 | 54 | 2 | IPR002919 | |
| Domain | Neurexin-like | 7.30e-04 | 14 | 54 | 2 | IPR003585 | |
| Domain | 4.1m | 7.30e-04 | 14 | 54 | 2 | SM00294 | |
| Domain | TSP_1 | 8.03e-04 | 63 | 54 | 3 | PF00090 | |
| Domain | TSP1 | 8.79e-04 | 65 | 54 | 3 | SM00209 | |
| Domain | TSP1_rpt | 8.79e-04 | 65 | 54 | 3 | IPR000884 | |
| Domain | TSP1 | 8.79e-04 | 65 | 54 | 3 | PS50092 | |
| Domain | Laminin_N | 9.59e-04 | 16 | 54 | 2 | IPR008211 | |
| Domain | Disintegrin_CS | 9.59e-04 | 16 | 54 | 2 | IPR018358 | |
| Domain | LAMININ_NTER | 9.59e-04 | 16 | 54 | 2 | PS51117 | |
| Domain | Laminin_N | 9.59e-04 | 16 | 54 | 2 | PF00055 | |
| Domain | LamNT | 9.59e-04 | 16 | 54 | 2 | SM00136 | |
| Domain | LCE | 1.09e-03 | 17 | 54 | 2 | PF14672 | |
| Domain | LCE | 1.09e-03 | 17 | 54 | 2 | IPR028205 | |
| Domain | ADAM_CR | 1.22e-03 | 18 | 54 | 2 | PF08516 | |
| Domain | - | 1.51e-03 | 20 | 54 | 2 | 4.10.70.10 | |
| Domain | MetalloPept_cat_dom | 1.66e-03 | 81 | 54 | 3 | IPR024079 | |
| Domain | - | 1.66e-03 | 81 | 54 | 3 | 3.40.390.10 | |
| Domain | Disintegrin | 1.66e-03 | 21 | 54 | 2 | PF00200 | |
| Domain | DISIN | 1.66e-03 | 21 | 54 | 2 | SM00050 | |
| Domain | Fibrinogen_a/b/g_C_2 | 2.17e-03 | 24 | 54 | 2 | IPR014715 | |
| Domain | - | 2.17e-03 | 24 | 54 | 2 | 4.10.530.10 | |
| Domain | ACR | 2.75e-03 | 27 | 54 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 2.75e-03 | 27 | 54 | 2 | IPR006586 | |
| Domain | Fibrinogen_C | 2.75e-03 | 27 | 54 | 2 | PF00147 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.37e-07 | 300 | 43 | 9 | M610 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.16e-05 | 258 | 43 | 7 | MM14572 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 3.91e-05 | 22 | 43 | 3 | M27084 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 5.80e-05 | 25 | 43 | 3 | M39713 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.21e-05 | 76 | 43 | 4 | M27219 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.23e-04 | 32 | 43 | 3 | MM14854 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 1.89e-04 | 7 | 43 | 2 | M47805 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 1.89e-04 | 7 | 43 | 2 | MM15703 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.91e-04 | 37 | 43 | 3 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.24e-04 | 39 | 43 | 3 | MM14601 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 2.52e-04 | 8 | 43 | 2 | M45025 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.21e-04 | 44 | 43 | 3 | M26969 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 3.23e-04 | 9 | 43 | 2 | M39869 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 3.23e-04 | 9 | 43 | 2 | M47866 | |
| Pathway | WP_1P36_COPY_NUMBER_VARIATION_SYNDROME | 3.67e-04 | 112 | 43 | 4 | M48072 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 4.77e-04 | 120 | 43 | 4 | MM14982 | |
| Pathway | WP_VITAMIN_B12_METABOLISM | 5.88e-04 | 54 | 43 | 3 | M39337 | |
| Pathway | WP_VITAMIN_B12_DISORDERS | 6.94e-04 | 13 | 43 | 2 | M39778 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 6.94e-04 | 13 | 43 | 2 | M47423 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.63e-04 | 59 | 43 | 3 | M27218 | |
| Pathway | REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM | 8.08e-04 | 14 | 43 | 2 | M27242 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 9.31e-04 | 15 | 43 | 2 | MM14762 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.06e-03 | 66 | 43 | 3 | M18 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.06e-03 | 16 | 43 | 2 | M47424 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.20e-03 | 17 | 43 | 2 | M39389 | |
| Pathway | REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM | 2.02e-03 | 22 | 43 | 2 | M27243 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.12e-03 | 84 | 43 | 3 | M7098 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 2.61e-03 | 25 | 43 | 2 | M118 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 3.04e-03 | 198 | 43 | 4 | M18311 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.04e-03 | 27 | 43 | 2 | M39545 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 3.04e-03 | 27 | 43 | 2 | M45550 | |
| Pubmed | 4.69e-10 | 175 | 57 | 8 | 28071719 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 30201140 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.30e-08 | 97 | 57 | 6 | 27559042 | |
| Pubmed | 1.67e-08 | 4 | 57 | 3 | 20301293 | ||
| Pubmed | 1.67e-08 | 4 | 57 | 3 | 34504132 | ||
| Pubmed | 4.16e-08 | 5 | 57 | 3 | 19047013 | ||
| Pubmed | 1.50e-07 | 146 | 57 | 6 | 27068509 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.68e-07 | 248 | 57 | 7 | 24006456 | |
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 2.32e-07 | 8 | 57 | 3 | 23055981 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 3.11e-07 | 86 | 57 | 5 | 28327460 | |
| Pubmed | 3.48e-07 | 9 | 57 | 3 | 12122015 | ||
| Pubmed | Efficient and fast targeted production of murine models based on ENU mutagenesis. | 1.87e-06 | 15 | 57 | 3 | 16075367 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 12399449 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 21851253 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 12429739 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19229767 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 2.64e-06 | 2 | 57 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 2.64e-06 | 2 | 57 | 2 | 21440062 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15131124 | ||
| Pubmed | Maternofetal transport of vitamin B12: role of TCblR/CD320 and megalin. | 2.64e-06 | 2 | 57 | 2 | 28351841 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 9321695 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 2.64e-06 | 2 | 57 | 2 | 12524050 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 2.64e-06 | 2 | 57 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 2.64e-06 | 2 | 57 | 2 | 8791520 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 8120105 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 8856503 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 35419902 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 2.64e-06 | 2 | 57 | 2 | 8307578 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 2.64e-06 | 2 | 57 | 2 | 10504303 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 2.64e-06 | 2 | 57 | 2 | 7744963 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 2.64e-06 | 2 | 57 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 2.64e-06 | 2 | 57 | 2 | 24833718 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 21402694 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 24265020 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20529844 | ||
| Pubmed | Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. | 2.64e-06 | 2 | 57 | 2 | 12359049 | |
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 2.64e-06 | 2 | 57 | 2 | 25524144 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 23430977 | ||
| Pubmed | Megalin (gp330): a putative endocytic receptor for thyroglobulin (Tg). | 2.64e-06 | 2 | 57 | 2 | 9492085 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17202312 | ||
| Pubmed | Fibrillin-2 and Tenascin-C bridge the age gap in lung epithelial regeneration. | 2.64e-06 | 2 | 57 | 2 | 28662401 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 23133647 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20558143 | ||
| Pubmed | The change in tenascin expression in mouse uterus during early pregnancy. | 2.64e-06 | 2 | 57 | 2 | 9013311 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 24867584 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 2.64e-06 | 2 | 57 | 2 | 16407178 | |
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 2.64e-06 | 2 | 57 | 2 | 1852206 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15455729 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 10359653 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 7509489 | ||
| Pubmed | The effects of tenascin C knockdown on trabecular meshwork outflow resistance. | 2.64e-06 | 2 | 57 | 2 | 23882691 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 16723719 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.91e-06 | 135 | 57 | 5 | 28675934 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 3.35e-06 | 18 | 57 | 3 | 35503090 | |
| Pubmed | 3.83e-06 | 64 | 57 | 4 | 22261194 | ||
| Pubmed | 4.06e-06 | 257 | 57 | 6 | 16335952 | ||
| Pubmed | 5.37e-06 | 153 | 57 | 5 | 25037231 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 5.44e-06 | 21 | 57 | 3 | 21337463 | |
| Pubmed | 5.80e-06 | 71 | 57 | 4 | 33541421 | ||
| Pubmed | 6.29e-06 | 22 | 57 | 3 | 27527664 | ||
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 7.91e-06 | 3 | 57 | 2 | 34133920 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 38891114 | ||
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 7.91e-06 | 3 | 57 | 2 | 7687262 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 10825173 | ||
| Pubmed | Generation and characterization of an inducible renal proximal tubule-specific CreERT2 mouse. | 7.91e-06 | 3 | 57 | 2 | 37215091 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 7530141 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15342463 | ||
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 7.91e-06 | 3 | 57 | 2 | 7694605 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 30858964 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18676613 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 28013231 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16406382 | ||
| Pubmed | Multiligand endocytosis and congenital defects: roles of cubilin, megalin and amnionless. | 7.91e-06 | 3 | 57 | 2 | 17979745 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 31812984 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 37209968 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 7.91e-06 | 3 | 57 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 7.91e-06 | 3 | 57 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 7.91e-06 | 3 | 57 | 2 | 29045040 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 31005376 | ||
| Pubmed | The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. | 7.91e-06 | 3 | 57 | 2 | 12823230 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 38571813 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 35173587 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 17293099 | ||
| Pubmed | Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report. | 7.91e-06 | 3 | 57 | 2 | 30567480 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18369154 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 7.91e-06 | 3 | 57 | 2 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 7.91e-06 | 3 | 57 | 2 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 7.91e-06 | 3 | 57 | 2 | 11944992 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 7.91e-06 | 3 | 57 | 2 | 17035546 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 7.91e-06 | 3 | 57 | 2 | 25423136 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 20855508 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 7959795 | ||
| Pubmed | 8.23e-06 | 167 | 57 | 5 | 22159717 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 12429738 | ||
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 1.58e-05 | 4 | 57 | 2 | 14983056 | |
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 1.58e-05 | 4 | 57 | 2 | 25406291 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 21540769 | ||
| Interaction | NTN5 interactions | 5.63e-09 | 24 | 56 | 5 | int:NTN5 | |
| Interaction | MFAP5 interactions | 3.25e-07 | 52 | 56 | 5 | int:MFAP5 | |
| Interaction | ZFP41 interactions | 5.18e-07 | 57 | 56 | 5 | int:ZFP41 | |
| Interaction | ZNF408 interactions | 3.02e-06 | 145 | 56 | 6 | int:ZNF408 | |
| Interaction | ZNF224 interactions | 2.24e-05 | 20 | 56 | 3 | int:ZNF224 | |
| Interaction | IGFL3 interactions | 5.61e-05 | 75 | 56 | 4 | int:IGFL3 | |
| Interaction | CILP interactions | 1.13e-04 | 6 | 56 | 2 | int:CILP | |
| Interaction | DLK2 interactions | 1.36e-04 | 36 | 56 | 3 | int:DLK2 | |
| Interaction | LRPAP1 interactions | 1.42e-04 | 180 | 56 | 5 | int:LRPAP1 | |
| Interaction | GREM2 interactions | 1.48e-04 | 37 | 56 | 3 | int:GREM2 | |
| Interaction | TRIM68 interactions | 1.79e-04 | 101 | 56 | 4 | int:TRIM68 | |
| Interaction | POFUT1 interactions | 2.32e-04 | 43 | 56 | 3 | int:POFUT1 | |
| GeneFamily | Low density lipoprotein receptors | 9.34e-09 | 13 | 36 | 4 | 634 | |
| GeneFamily | Fibulins | 1.07e-04 | 8 | 36 | 2 | 556 | |
| GeneFamily | Late cornified envelope proteins | 5.78e-04 | 18 | 36 | 2 | 627 | |
| GeneFamily | Fibrinogen C domain containing | 1.12e-03 | 25 | 36 | 2 | 554 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.31e-03 | 27 | 36 | 2 | 47 | |
| Coexpression | NABA_MATRISOME | ADAMTS10 HGFAC NTN4 FBLN7 FAM20C FBN1 FBN2 HMCN1 MEGF6 CILP TNC BRINP2 LAMA2 LTBP2 MUC13 ADAM32 MFRP ADAM8 F7 TNXB | 1.31e-14 | 1008 | 57 | 20 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS10 HGFAC NTN4 FBLN7 FAM20C FBN1 FBN2 HMCN1 MEGF6 CILP TNC BRINP2 LAMA2 LTBP2 MUC13 ADAM32 ADAM8 F7 TNXB | 2.41e-13 | 1026 | 57 | 19 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.07e-11 | 191 | 57 | 10 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.38e-11 | 196 | 57 | 10 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 3.21e-10 | 270 | 57 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 3.84e-10 | 275 | 57 | 10 | M5884 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS10 HGFAC FAM20C MEGF6 BRINP2 MUC13 ADAM32 MFRP ADAM8 F7 | 3.85e-06 | 738 | 57 | 10 | MM17058 |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 2.17e-05 | 25 | 57 | 3 | M47986 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP | 2.43e-05 | 398 | 57 | 7 | M4872 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.26e-05 | 751 | 57 | 9 | M5885 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.07e-05 | 35 | 57 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.62e-05 | 36 | 57 | 3 | MM1212 | |
| Coexpression | GSE14026_TH1_VS_TH17_UP | 7.46e-05 | 200 | 57 | 5 | M3356 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 7.46e-05 | 200 | 57 | 5 | M7289 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 9.10e-05 | 40 | 57 | 3 | M5887 | |
| Coexpression | NABA_ECM_REGULATORS | 1.69e-04 | 238 | 57 | 5 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.82e-04 | 242 | 57 | 5 | MM17062 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 2.21e-04 | 567 | 57 | 7 | M2129 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.59e-04 | 261 | 57 | 5 | M1834 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 2.91e-04 | 59 | 57 | 3 | M47993 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 2.91e-04 | 59 | 57 | 3 | M47989 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-12 | 195 | 57 | 9 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-10 | 200 | 57 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-09 | 181 | 57 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.65e-09 | 183 | 57 | 7 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-09 | 186 | 57 | 7 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.41e-09 | 188 | 57 | 7 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.10e-09 | 192 | 57 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-09 | 200 | 57 | 7 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.76e-08 | 155 | 57 | 6 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 7.41e-08 | 167 | 57 | 6 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class | 1.05e-07 | 177 | 57 | 6 | 34e9455790bae905dd91923792f4109d18b7686e | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.12e-07 | 179 | 57 | 6 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-07 | 180 | 57 | 6 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-07 | 182 | 57 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-07 | 182 | 57 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-07 | 183 | 57 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.36e-07 | 185 | 57 | 6 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-07 | 185 | 57 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-07 | 185 | 57 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-07 | 185 | 57 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.45e-07 | 187 | 57 | 6 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-07 | 188 | 57 | 6 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 1.54e-07 | 189 | 57 | 6 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 189 | 57 | 6 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-07 | 191 | 57 | 6 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-07 | 191 | 57 | 6 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-07 | 192 | 57 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-07 | 192 | 57 | 6 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-07 | 192 | 57 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-07 | 193 | 57 | 6 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.74e-07 | 193 | 57 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.80e-07 | 194 | 57 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.85e-07 | 195 | 57 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-07 | 195 | 57 | 6 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.85e-07 | 195 | 57 | 6 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 196 | 57 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 196 | 57 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-07 | 196 | 57 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-07 | 196 | 57 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.97e-07 | 197 | 57 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-07 | 197 | 57 | 6 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-07 | 197 | 57 | 6 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-07 | 198 | 57 | 6 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-07 | 198 | 57 | 6 | 7d2fe57e0f9311ac1e6854402ebc154306eb1ba5 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.03e-07 | 198 | 57 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.09e-07 | 199 | 57 | 6 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.09e-07 | 199 | 57 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.09e-07 | 199 | 57 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 57 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.15e-07 | 200 | 57 | 6 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.15e-07 | 200 | 57 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-07 | 200 | 57 | 6 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_CTL|Bac-SEP / Disease, condition lineage and cell class | 2.15e-07 | 200 | 57 | 6 | 78cce90288ee7224067f7b87c99c54737bed466d | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.15e-07 | 200 | 57 | 6 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 57 | 6 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-07 | 200 | 57 | 6 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-07 | 200 | 57 | 6 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.15e-07 | 200 | 57 | 6 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-06 | 153 | 57 | 5 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD4_CTL|Bac-SEP / Disease, Lineage and Cell Type | 1.81e-06 | 158 | 57 | 5 | 4beed58bf58253253fc7e5009294b35e3bb8eae3 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.87e-06 | 159 | 57 | 5 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-gdT|ICU-NoSEP / Disease, Lineage and Cell Type | 1.93e-06 | 160 | 57 | 5 | 2798c5bd971407f27dd4d3a4831d63d9c88003c3 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.17e-06 | 164 | 57 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | BAL-Severe-cDC_2|Severe / Compartment, Disease Groups and Clusters | 2.31e-06 | 166 | 57 | 5 | 602a72a607534d5f21eddd2c7a52a57084f4920f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-06 | 167 | 57 | 5 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.45e-06 | 168 | 57 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class | 2.52e-06 | 169 | 57 | 5 | 8c8168ac93a808d7b4756e4491db2b2979df1c1f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 175 | 57 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-06 | 176 | 57 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-06 | 176 | 57 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.07e-06 | 176 | 57 | 5 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-06 | 177 | 57 | 5 | 0417460bdb012bc43d7254377fa53d79cdab3f34 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-06 | 179 | 57 | 5 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.43e-06 | 180 | 57 | 5 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-06 | 180 | 57 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.43e-06 | 180 | 57 | 5 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| ToppCell | Control-Myeloid-MoAM2|Control / Disease group,lineage and cell class （2021.01.30） | 3.43e-06 | 180 | 57 | 5 | 38892483a6a5388765aec87f0119c0b9bb5c7cbd | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 180 | 57 | 5 | ff34195bb7325e61fbf823c103c5e6115d8f1248 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.52e-06 | 181 | 57 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.62e-06 | 182 | 57 | 5 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-06 | 182 | 57 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-06 | 182 | 57 | 5 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.82e-06 | 184 | 57 | 5 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 3.82e-06 | 184 | 57 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-06 | 184 | 57 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-06 | 185 | 57 | 5 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.92e-06 | 185 | 57 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.02e-06 | 186 | 57 | 5 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-06 | 186 | 57 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.02e-06 | 186 | 57 | 5 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.13e-06 | 187 | 57 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.13e-06 | 187 | 57 | 5 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.13e-06 | 187 | 57 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 187 | 57 | 5 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.13e-06 | 187 | 57 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 187 | 57 | 5 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 187 | 57 | 5 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 187 | 57 | 5 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.13e-06 | 187 | 57 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.24e-06 | 188 | 57 | 5 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| Computational | Adhesion molecules. | 1.28e-04 | 141 | 38 | 5 | MODULE_122 | |
| Drug | monatepil | 7.45e-07 | 29 | 56 | 4 | CID000060810 | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A | 7.61e-06 | 192 | 56 | 6 | 5101_UP | |
| Drug | benzamidine | 3.07e-05 | 147 | 56 | 5 | CID000002332 | |
| Drug | 3-ethylpyridine | 3.55e-05 | 4 | 56 | 2 | CID000010823 | |
| Drug | Salmfamide 1 | 3.55e-05 | 4 | 56 | 2 | CID005487416 | |
| Drug | dimethylaminopropylamine | 3.55e-05 | 4 | 56 | 2 | CID000007993 | |
| Disease | Weill-Marchesani syndrome | 6.47e-09 | 3 | 56 | 3 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 6.47e-09 | 3 | 56 | 3 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 6.47e-09 | 3 | 56 | 3 | C1869114 | |
| Disease | Weill-Marchesani syndrome | 2.59e-08 | 4 | 56 | 3 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 2.59e-08 | 4 | 56 | 3 | DOID:0050475 (is_implicated_in) | |
| Disease | Scoliosis, unspecified | 3.60e-07 | 8 | 56 | 3 | C0036439 | |
| Disease | intraocular pressure measurement | 5.10e-06 | 509 | 56 | 8 | EFO_0004695 | |
| Disease | cortical thickness | FBLN7 ZNF469 FBN1 FBN2 LAMA2 TRIOBP LRP4 TNRC6B FAM53B CRB2 TG | 6.56e-06 | 1113 | 56 | 11 | EFO_0004840 |
| Disease | connective tissue disease (implicated_via_orthology) | 1.06e-05 | 3 | 56 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 1.06e-05 | 3 | 56 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 2.12e-05 | 4 | 56 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | FEV/FEC ratio | 9.34e-05 | 1228 | 56 | 10 | EFO_0004713 | |
| Disease | creatinine measurement | 9.91e-05 | 995 | 56 | 9 | EFO_0004518 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.42e-04 | 53 | 56 | 3 | C4707243 | |
| Disease | ascending aortic diameter | 1.47e-04 | 140 | 56 | 4 | EFO_0021787 | |
| Disease | tenascin measurement | 1.58e-04 | 10 | 56 | 2 | EFO_0008296 | |
| Disease | Marfan Syndrome | 1.92e-04 | 11 | 56 | 2 | C0024796 | |
| Disease | cortical surface area measurement | 1.96e-04 | 1345 | 56 | 10 | EFO_0010736 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 2.31e-04 | 12 | 56 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | central corneal thickness | 3.01e-04 | 309 | 56 | 5 | EFO_0005213 | |
| Disease | cortisol measurement | 6.58e-04 | 20 | 56 | 2 | EFO_0005843 | |
| Disease | eye colour measurement | 7.88e-04 | 218 | 56 | 4 | EFO_0009764 | |
| Disease | corpus callosum volume measurement | 9.19e-04 | 100 | 56 | 3 | EFO_0010299 | |
| Disease | temperament and character inventory | 9.51e-04 | 24 | 56 | 2 | EFO_0004825 | |
| Disease | familial hyperlipidemia | 1.09e-03 | 106 | 56 | 3 | MONDO_0001336 | |
| Disease | body surface area | 1.35e-03 | 643 | 56 | 6 | EFO_0022196 | |
| Disease | Drug habituation | 1.38e-03 | 115 | 56 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 1.38e-03 | 115 | 56 | 3 | C0236969 | |
| Disease | Drug abuse | 1.38e-03 | 115 | 56 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 1.38e-03 | 115 | 56 | 3 | C0013222 | |
| Disease | Drug Dependence | 1.38e-03 | 115 | 56 | 3 | C1510472 | |
| Disease | Substance Dependence | 1.38e-03 | 115 | 56 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 1.38e-03 | 115 | 56 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.38e-03 | 115 | 56 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.38e-03 | 115 | 56 | 3 | C4316881 | |
| Disease | Substance abuse problem | 1.41e-03 | 116 | 56 | 3 | C0740858 | |
| Disease | thoracic aortic aneurysm | 1.49e-03 | 30 | 56 | 2 | EFO_0004282 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.58e-03 | 447 | 56 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | corneal resistance factor | 1.64e-03 | 451 | 56 | 5 | EFO_0010067 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.65e-03 | 914 | 56 | 7 | EFO_0004532 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSASPEQVPAGECCA | 126 | Q9NVI7 | |
| DSCNGDSGSPLLCEG | 206 | P12544 | |
| DSPCAQECVNTPGGF | 351 | Q9NPY3 | |
| AENCNGTSPECGPDI | 461 | Q8TC27 | |
| ADPSGCVCGNAEAQP | 206 | Q9BXJ7 | |
| NPCANGGSCSETPRS | 281 | Q9NYJ7 | |
| CPEDAFQENGTPCSG | 486 | P78325 | |
| QQCEAKCDSPTPGDG | 1051 | Q9H324 | |
| SSNAPGSCSPDGVDQ | 461 | P26045 | |
| CTDGSDDNCSGPLFP | 446 | Q9BY79 | |
| GGSFQCVSPECPEGS | 291 | Q53RD9 | |
| DCPDGSDEENCTANP | 96 | Q86YD5 | |
| PCAPGTECQATESGG | 46 | Q5IJ48 | |
| DGSPCEGGSPAANCS | 1146 | Q5IJ48 | |
| GESCDNANSTCPIGG | 366 | Q9NR71 | |
| PDCPDSSDELGCGTN | 156 | Q9NPF0 | |
| SCLSAGTEDCGPQSP | 311 | Q14153 | |
| CGDGSDEGNCSAPAS | 191 | O75074 | |
| SPGNPGGSCQECECD | 1516 | P24043 | |
| NAGSECACSEDPAAP | 91 | A0A0U1RRK4 | |
| FDCPNGTDESPLCNG | 1336 | P98164 | |
| GTDESPLCNGNSCSD | 1341 | P98164 | |
| SDACQGDSGGPLACE | 591 | Q04756 | |
| GSDVQSDFCNSDPCP | 4741 | Q96RW7 | |
| PSGGPCQAERDDSDC | 426 | P58401 | |
| CSRACSAGEDPNGSD | 306 | Q7Z3G6 | |
| ADGPCFNGGRCSDSP | 371 | O00548 | |
| SGEPGCSCAQPAAEV | 41 | Q8IXL6 | |
| ALSAPPQCQDGCAEG | 1551 | Q9Y6R7 | |
| DTDECSVGNPCGNGT | 2166 | P35555 | |
| LCPANEGNCGGSAPS | 41 | Q5VUE5 | |
| NCLCETGFQPSPESG | 1241 | Q14767 | |
| HQSPDCCESEPSGGS | 86 | O14633 | |
| HQSPDCCESEPSGGS | 86 | Q5TA81 | |
| SNPCTNGDCVNTPGS | 541 | P35556 | |
| SDNSGCDAPGNSNPS | 341 | Q99590 | |
| AFSSRCQPGGEDPSC | 116 | P80192 | |
| SGCEQACPPGSFGED | 1156 | O75095 | |
| PANSVTFCDPSNGDC | 406 | Q9HB63 | |
| PSPPDKGDNASNCDC | 186 | A1A5C7 | |
| DGDQCASSPCQNGGS | 106 | P08709 | |
| AGLPCLSDQGSDGCD | 381 | Q9HDB5 | |
| DQCLAPDTSGDGTGC | 481 | O15355 | |
| SLCGSCNEDPGSDPT | 121 | Q9H2D6 | |
| GEGPACAHCAPDNST | 461 | Q9C0B6 | |
| TGPNGACVPAFCDDQ | 801 | O75339 | |
| TGPSNPCQDDPCADN | 171 | Q9H3R2 | |
| LGFADGSCDPSDQCP | 31 | Q8NDY8 | |
| PSASGSCPDDCNDQG | 181 | P22105 | |
| GFTGPDCAELSCPND | 521 | P24821 | |
| NGPRFGQSPSCACED | 516 | Q5GH76 | |
| DSCQGDSGGPLACEE | 681 | Q7Z410 | |
| PASSSCLCQDGEDAG | 1381 | Q96JG9 | |
| QQGEPPSCAEGQSCA | 351 | P01266 | |
| DGFDSPSCGSQCRPT | 236 | Q86WV1 | |
| PFSNQDGCLGDEAPC | 1141 | Q9UPQ9 | |
| GASDSEGRNTACPCP | 296 | Q9H0D2 | |
| DNGSDEQGCPPKTCS | 96 | P01130 | |
| CNGVNDCGDNSDESP | 331 | O75096 |